Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Merck
US Army
Federal Trade Commission
QuintilesIMS
Citi
Argus Health
Colorcon
Queensland Health
Harvard Business School

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017484

« Back to Dashboard

NDA 017484 describes DEXTROSE 5% AND ELECTROLYTE NO. 48 IN PLASTIC CONTAINER, which is a drug marketed by Baxter Hlthcare and is included in one NDA. It is available from one supplier. Additional details are available on the DEXTROSE 5% AND ELECTROLYTE NO. 48 IN PLASTIC CONTAINER profile page.

The generic ingredient in DEXTROSE 5% AND ELECTROLYTE NO. 48 IN PLASTIC CONTAINER is dextrose; magnesium chloride; potassium chloride; potassium phosphate, monobasic; sodium chloride; sodium lactate. There are eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the dextrose; magnesium chloride; potassium chloride; potassium phosphate, monobasic; sodium chloride; sodium lactate profile page.
Suppliers and Packaging for NDA: 017484
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DEXTROSE 5% AND ELECTROLYTE NO. 48 IN PLASTIC CONTAINER dextrose; magnesium chloride; potassium chloride; potassium phosphate, monobasic; sodium chloride; sodium lactate INJECTABLE;INJECTION 017484 NDA Baxter Healthcare Corporation 0338-0143 0338-0143-03 500 mL in 1 BAG (0338-0143-03)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength5GM/100ML;31MG/100ML;141MG/100ML;20MG/100ML;12MG/100ML;260MG/100ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Accenture
McKinsey
Fuji
US Army
UBS
Dow
Queensland Health
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot